Covered recipient · General Payments record
ANDREA H KOVACIC
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$427.59
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $207.55 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $53.62 | 3 |
| Acerta Pharma LLC | $29.29 | 2 |
| Astellas Pharma US Inc | $26.80 | 1 |
| Novo Nordisk AS | $18.19 | 1 |
| CeQur Corporation | $17.18 | 1 |
| GlaxoSmithKline, LLC. | $17.12 | 1 |
| Lilly USA, LLC | $15.59 | 1 |
| ABBVIE INC. | $14.90 | 1 |
| Kowa Pharmaceuticals America, Inc. | $14.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.90 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104104062 | CMS |
| Astellas Pharma US Inc | $26.80 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139362161 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.93 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105735565 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.36 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105459271 | CMS |
| CeQur Corporation | $17.18 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126847674 | CMS |
| GlaxoSmithKline, LLC. | $17.12 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115851992 | CMS |
| Kowa Pharmaceuticals America, Inc. | $14.86 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113467615 | CMS |
| Lilly USA, LLC | $15.59 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136035598 | CMS |
| Novo Nordisk Inc | $18.19 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096976178 | CMS |
| PFIZER INC. | $18.32 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131032616 | CMS |
| PFIZER INC. | $18.95 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131208129 | CMS |
| PFIZER INC. | $16.35 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131978655 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.